- This is a 2-part education series comprised of 2 one-hour interactive webinars.
- Participants are encouraged to attend both sessions and can earn up to 1.0 CME credit or nursing contact hours for each session attended.
Educational Session 2
- Faculty will present cases relevant to screening and identifying liver disease cases likely to present at community practices.
- Participants will discuss challenging liver disease cases to expert faculty.
- Participants will discuss implementation of the screening algorithm at their center and any challenges faced.
- Select one of the offerings:
Wednesday, May 12th from 12:00-1:00 PM CT (https://may12_liverdisease_webex.eventbrite.com)
Thursday, May 13th from 6:30-7:30 PM CT (https://may13_liverdisease_webex.eventbrite.com)
This activity was developed for physicians, nurse practitioners, physician assistants, nurses and other healthcare professionals from community practices in regions that have patient populations with disproportionately high rates of advanced liver disease and hepatocellular carcinoma.
At the conclusion of this activity, participants should be better able to:
- Describe straightforward methods to identify patients with possible advanced liver disease and hepatocellular carcinoma in community practices.
- Integrate advances in therapeutic and diagnostic modalities in liver disease into clinical practice.
Carmen Landaverde, MD Jennifer Wells, MD
Director, Metabolic Liver Disease Program Director, Regenerative Liver and Neoplasia
Texas Liver Institute (TLI), Austin Texas Liver Institute (TLI), Austin
Accreditation and Certification
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Texas Liver Institute. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is co-provided by the Annenberg Center for Health Sciences at Eisenhower and the Texas Liver Institute.
Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 1.0 contact hours may be earned for successful completion of this activity.
This activity is supported by an independent educational grant from AbbVie, Mallinckrodt and Salix.
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in accredited educational activities are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, disclosure information will be provided at the beginning of the activity.